Rheumatic diseases should be actively treated in pregnancy, new guidelines sayBMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i312 (Published 19 January 2016) Cite this as: BMJ 2016;352:i312
- Jacqui Wise
New guidelines on prescribing anti-rheumatic drugs for pregnant and breastfeeding women, published in the Rheumatology journal, warn against withdrawing potentially beneficial treatment and recommend the best treatment approaches.
Prescription of many anti-rheumatic drugs in pregnancy is complicated by safety concerns, and this has sometimes led to the withdrawal of potentially beneficial treatment. But the new guidelines, produced by the British Society for Rheumatology and British Health Professionals in Rheumatology,1 2 say …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial